for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Soiken Holdings Inc

2385.T

Latest Trade

516.00JPY

Change

-20.00(-3.73%)

Volume

774,800

Today's Range

511.00

 - 

536.00

52 Week Range

379.00

 - 

736.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
536.00
Open
530.00
Volume
774,800
3M AVG Volume
10.51
Today's High
536.00
Today's Low
511.00
52 Week High
736.00
52 Week Low
379.00
Shares Out (MIL)
26.16
Market Cap (MIL)
14,020.79
Forward P/E
--
Dividend (Yield %)
0.75

Next Event

Dividend For 2385.T - 0.0000 JPY

Latest Developments

More

Soiken Holdings says change of president

Soiken Holdings confirms amount of share purchase of NRL Pharma

Soiken Holdings to buy 58.6 pct stake in NRL Pharma

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Soiken Holdings Inc

Soiken Holdings Inc. is a Japan-based holding company. The Company operates in six business segments. The Biological Evaluation System segment is engaged in evaluation test of food and research support of medicine. The Healthcare Support segment is engaged in the provision of service about certain health guidance and healthcare insurance. The Cosmetics segment is engaged in manufacturing and sales of cosmetics. The Dietary Supplements segment is engaged in sales of unique dietary supplements. The Marketing segment is engaged in the marketing research of health supplement and sales of energy drink. The Functional Material Development segment is engaged in development and sales of functional materials, such as lactoferrin.

Industry

Retail (Grocery)

Contact Info

13F, Senri Life Science Center

1-4-2, Shinsenri Higashi-machi

+81.6.68718888

http://www.soiken.com/

Executive Leadership

Kentaro Ishigami

President, Representative Director

Osamu Tanabe

Director of Finance, Director of General Affairs, Director

Tomohiro Sugino

President of Subsidiary, Director

Osami Kajimoto

Non-Executive Director

Key Stats

Price To Earnings (TTM)
28.98
Price To Sales (TTM)
1.82
Price To Book (MRQ)
3.01
Price To Cash Flow (TTM)
18.70
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
11.23
Return on Equity (TTM)
8.54

Latest News

Latest News

BRIEF- Soiken Holdings confirms amount of share purchase of NRL Pharma

* Says it confirms to acquire 64.5 percent voting power in NRL Pharma Inc for 574 million yen in total

BRIEF-Soiken Holdings to buy 58.6 pct stake in NRL Pharma

* Says it plans to buy 58.6 percent stake in NRL Pharma Inc for totaling 528 million yen, on June 27

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up